Apricus Wealth, LLC Relmada Therapeutics, Inc. Transaction History
Apricus Wealth, LLC
- $162 Million
- Q1 2025
A detailed history of Apricus Wealth, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Apricus Wealth, LLC holds 48,962 shares of RLMD stock, worth $32,314. This represents 0.01% of its overall portfolio holdings.
Number of Shares
48,962
Previous 48,962
-0.0%
Holding current value
$32,314
Previous $25,000
48.0%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding RLMD
# of Institutions
49Shares Held
6.3MCall Options Held
0Put Options Held
0-
Acadian Asset Management LLC Boston, MA1.23MShares$810,4320.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$797,3290.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$378,3870.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$326,7960.03% of portfolio
-
Geode Capital Management, LLC Boston, MA302KShares$199,2420.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $18.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...